Pollen & Mold

Atlanta Allergy Pollen Count for 08/16/2019: 11
more info

Trees

Grass

Weeds


Mold Activity for 08/16/2019:

Sign up for our Pollen Count email.

Newsletter Sign Up

Stay up to date with the latest news from Atlanta Allergy & Asthma.

Latest Post

Facebook
August 17, 2019

The IRS recently updated their policies that could make asthma control medicines more affordable if you have a high deductible health plan (HDHP). Read more here: https://bit.ly/2GXmvly.

FDA Approves New Treatment Option for Patients with Severe Asthma.

Friday, November 6, 2015

Atlanta Allergy & Asthma News
The U.S. Food and Drug Administration has recently approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older.

Nucala is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines. If you or your child are not well controlled, we encourage you to schedule a follow up appointment to discuss this treatment option with your Atlanta Allergy & Asthma physician.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm471031.htm